申请人:UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
公开号:US20200108050A1
公开(公告)日:2020-04-09
Some embodiments of the invention include methods of using a compound such as Formula (I), Formula (II), or I-1 (e.g., in compositions or in pharmaceutical compositions) for treating diseases (e.g., cancer such as chemo-resistant cancer or cancer-therapy-resistant cancer). Additional embodiments of the invention are also discussed herein.